Review

Medical management of benign prostatic hyperplasia

Eiftu S. Haile, MD, Ayodeji E. Sotimehin, MD and Bradley C. Gill, MD, MS
Cleveland Clinic Journal of Medicine March 2024, 91 (3) 163-170; DOI: https://doi.org/10.3949/ccjm.91a.23027

Article Figures & Data

Figures

  • Figure 1
    Figure 1

    Algorithmic approach to medical management of benign prostatic hyperplasia.

    5ARI = 5-alpha reductase inhibitors; LUTS = lower urinary tract symptoms; OAB = overactive bladder; PDE5i = phosphodiesterase-5 inhibitor

    Adapted from the American Urological Association guidelines.7

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects